Rhonda L LaFleur

Summary

Affiliation: Intervet International BV
Country: The Netherlands

Publications

  1. pmc Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease
    Rhonda L LaFleur
    Schering Plough Animal Health Corporation, Elkhorn, Nebraska 68022 2202, USA
    Clin Vaccine Immunol 16:253-9. 2009
  2. pmc One-year duration of immunity induced by vaccination with a canine Lyme disease bacterin
    Rhonda L LaFleur
    Intervet Schering Plough Animal Health Corporation, 21401 W Center Road, Elkhorn, NE 68022 2202, USA
    Clin Vaccine Immunol 17:870-4. 2010
  3. pmc Vaccination with the ospA- and ospB-Negative Borrelia burgdorferi Strain 50772 Provides Significant Protection against Canine Lyme Disease
    Rhonda L LaFleur
    Merck Animal Health, Inc, Elkhorn, Nebraska, USA
    Clin Vaccine Immunol 22:836-9. 2015

Detail Information

Publications3

  1. pmc Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease
    Rhonda L LaFleur
    Schering Plough Animal Health Corporation, Elkhorn, Nebraska 68022 2202, USA
    Clin Vaccine Immunol 16:253-9. 2009
    ..The results therefore confirmed that the bacterin provided a high level of protection against Lyme disease shortly after immunization...
  2. pmc One-year duration of immunity induced by vaccination with a canine Lyme disease bacterin
    Rhonda L LaFleur
    Intervet Schering Plough Animal Health Corporation, 21401 W Center Road, Elkhorn, NE 68022 2202, USA
    Clin Vaccine Immunol 17:870-4. 2010
    ..006), or Lyme disease-specific antibody responses (P = 0.002). The bacterin provided a high level of protection for 1 year after immunization, and the addition of the OspC-producing B. burgdorferi 50772 provided enhanced protection...
  3. pmc Vaccination with the ospA- and ospB-Negative Borrelia burgdorferi Strain 50772 Provides Significant Protection against Canine Lyme Disease
    Rhonda L LaFleur
    Merck Animal Health, Inc, Elkhorn, Nebraska, USA
    Clin Vaccine Immunol 22:836-9. 2015
    ..In addition, 9 (90%) placebo recipients and 4 (40%) vaccine recipients developed joint abnormalities (P = 0.0573). Therefore, vaccination with the ospA- and ospB-negative spirochete provided significant protection against Lyme disease. ..